[Exogenous adrenergic stimulation by intravenous infusions of isoproterenol and blood levels of cyclic AMP before and after beta-blocking in humans].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D000242:Cyclic AMP / Q000097:blood*; D006152:Cyclic GMP / Q000097:blood; D004983:Ethanolamines / Q000494:pharmacology*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000503:physiopathology; D007545:Isoproterenol / Q000494:pharmacology*; D007741:Labetalol / Q000494:pharmacology*; D008297:Male; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects; D011943:Receptors, Adrenergic, beta / Q000187:drug effects*; D013564:Sympathetic Nervous System / Q000503:physiopathology
D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D000242:Cyclic AMP; D006152:Cyclic GMP; D007545:Isoproterenol; D007741:Labetalol
Stimolazione adrenergica esogena da infusione endovenosa di isoproterenolo e livelli plasmatici di AMP ciclico prima e dopo betablocco nell'uomo.